EIDD-1931

Overview

EIDD-1931 is a ribonucleoside analog that exhibits potential antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV. EIDD-1931 induces mutations in RNA virions, inhibiting SARS-CoV-2 and other coronavirus in mice and human airway epithelial cells.

Application

Products > Drug Discovery > Inhibitor > SARS-CoV-2 Inhibitors | Products > Drug Discovery > Inhibitor | Infection

Product Information

• Catalog No.: B2693-338763
• CAS No.: 3258-02-4
• Molecular Formula: C9H13N3O6
• Molecular Weight: 259.22
• Purity: 99.73%
• Storage: Powder : -20°C: 3 years 4°C: 2 years * The compound is unstable in solutions, freshly prepared is recommended.
• Solubility: In Vitro : DMSO : 100 mg/mL(385.77 mM;Need ultrasonic) In Vivo: 1.Add each solvent one by one:10% DMSO >> 40%PEG300 >> 5%Tween-80 >> 45% saline Solubility: ≥ 2.08 mg/mL (8.02 mM); Clear solution 2.Add each solvent one by one:10% DMSO >> 90% (20%SBE-β-CDin saline) Solubility: ≥ 2.08 mg/mL (8.02 mM); Clear solution 3.Add each solvent one by one:10% DMSO >> 90%corn oil Solubility: ≥ 2.08 mg/mL (8.02 mM); Clear solution

Source

Original product source